Multimodal Explainable AI Outperforms Standard Biomarkers for Lung Cancer Immunotherapy Decisions
Predicting which lung cancer patients will respond to immunotherapy remains one of oncology's most consequential…
Predicting which lung cancer patients will respond to immunotherapy remains one of oncology's most consequential…
Predicting which cancer patients will actually respond to immunotherapy remains one of oncology's most pressing…
The assumption that the restorative power of sleep is inseparable from sleep itself may be fundamentally wrong. A…
Nearly half of all Alzheimer's disease cases may be preventable, yet the United States has been remarkably slow to…
Pooling three randomized controlled trials — MAVERICK-HCM, ODYSSEY-HCM, and ACACIA-HCM — across 1,156 adults with…
A pragmatic, multicentre randomized trial enrolling 300 Indian adults with untreated or undertreated hypertension has…
Pooled analysis of ten echocardiography-confirmed studies across Nepal — encompassing 209,815 participants and 5,440…
Pooling eight observational studies covering 21,708 Nepalese adults, this systematic review estimates metabolic…
Across 18,499,626 FDA Adverse Event Reporting System cases from 2000–2024, two psychoactive substances stand out for…
As GLP-1 receptor agonists like semaglutide and tirzepatide reach tens of millions of users globally, questions about…
Chronic dental infections that quietly destroy jawbone affect hundreds of millions of people globally, yet treatment…
Small-cell lung cancer's brutal biology — rapid progression, early metastasis, and near-universal resistance to…
Immune checkpoint inhibitors transformed lung cancer treatment, yet most patients who initially respond eventually…
Rising ADHD and autism diagnoses have long been attributed to shifting awareness and diagnostic criteria — but a new…
The prospect of testing thousands of drug combinations in a living tumor cell — without touching a single patient…
Most GLP-1 drugs are prescribed for blood sugar and weight — but if their longevity effects in mammals generalize…
Pancreatic cancer remains one of oncology's most intractable challenges, with five-year survival rates stubbornly…
The GLP-1 drug class has rapidly transformed metabolic medicine, but a fundamental question has lingered: are its…
For the roughly one-third of adults who fall into cardiovascular risk's frustrating middle ground — not clearly…
Tirzepatide combination therapy in psoriasis patients achieved enhanced skin clearance alongside substantial weight…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.